​

Ardent Health Partners (ARDT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ARDT Stock Forecast

Ardent Health Partners (ARDT) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $14.14, with a high of $19.00 and a low of $12.00. This represents a 56.59% increase from the last price of $9.03.

$9 $11 $13 $15 $17 $19 High: $19 Avg: $14.14 Low: $12 Last Closed Price: $9.03

ARDT Stock Rating

Ardent Health Partners stock's rating consensus is Buy, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (66.67%), 3 Hold (25.00%), 1 Sell (8.33%), and 0 Strong Sell (0.00%).

Buy
Total 12 0 1 3 8 Strong Sell Sell Hold Buy Strong Buy

ARDT Price Target Upside V Benchmarks

TypeNameUpside
StockArdent Health Partners56.59%
SectorHealthcare Stocks 15.45%
IndustryMedical Care Facilities Stocks24.44%

Price Target Trends

1M3M12M
# Anlaysts1110
Avg Price Target$13.00$13.00$14.50
Last Closing Price$9.03$9.03$9.03
Upside/Downside43.96%43.96%60.58%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 26174-113
Feb, 26174-113
Jan, 26174-113
Dec, 25174-113
Nov, 25282-113
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 09, 2026Ben HendrixRBC Capital$13.00$9.1741.77%43.96%
Dec 18, 2025UBS$14.00$8.9456.60%55.04%
Dec 18, 2025Ann HynesMizuho Securities$12.00$8.9434.23%32.89%
Nov 18, 2025Mizuho Securities$13.00$8.7049.43%43.96%
Nov 14, 2025Whit MayoLeerink Partners$16.00$9.0177.58%77.19%
Nov 14, 2025Truist Financial$13.00$8.9245.74%43.96%
Nov 14, 2025Ben HendrixRBC Capital$16.00$8.9778.37%77.19%
Nov 14, 2025Morgan Stanley$12.00$9.3029.03%32.89%
Oct 14, 2025Goldman Sachs$19.00$14.1334.47%110.41%
Sep 10, 2025UBS$17.00$13.0330.47%88.26%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 09, 2026RBC CapitalOutperformOutperformhold
Nov 17, 2025KeyBancOverweightSector Weightdowngrade
Nov 14, 2025RBC CapitalOutperformOutperformhold
Oct 14, 2025Goldman SachsNeutralinitialise
Sep 10, 2025UBSBuyinitialise
Mar 04, 2025RBC CapitalOutperformOutperformhold
Nov 06, 2024Bank of America SecuritiesNeutraldowngrade
Oct 10, 2024KeyBancOverweightinitialise
Sep 19, 2024StephensOverweightOverweighthold
Aug 16, 2024Loop Capital MarketsBuyBuyhold

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$0.35$1.59$0.96--
Avg Forecast$0.18$1.22$1.99$2.19$2.38
High Forecast$0.18$1.31$2.14$2.46$2.51
Low Forecast$0.18$1.06$1.84$2.05$2.25
Surprise %94.44%30.33%-51.76%--

Revenue Forecast

$5B $6B $6B $7B $7B $8B Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$5.41B$5.97B$6.32B--
Avg Forecast$5.63B$5.85B$6.32B$6.68B$7.09B
High Forecast$5.66B$5.86B$6.36B$6.74B$7.15B
Low Forecast$5.59B$5.84B$6.29B$6.60B$7.00B
Surprise %-3.98%1.98%0.07%--

Net Income Forecast

$0 $80M $160M $240M $320M $400M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$50.29M$210.34M$135.81M--
Avg Forecast$25.47M$169.77M$277.05M$314.47M$340.30M
High Forecast$25.68M$187.67M$306.58M$352.43M$359.59M
Low Forecast$25.26M$151.86M$263.60M$293.69M$322.34M
Surprise %97.47%23.90%-50.98%--

ARDT Forecast FAQ

Is Ardent Health Partners stock a buy?

Ardent Health Partners stock has a consensus rating of Buy, based on 12 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 3 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Ardent Health Partners is a favorable investment for most analysts.

What is Ardent Health Partners's price target?

Ardent Health Partners's price target, set by 12 Wall Street analysts, averages $14.14 over the next 12 months. The price target range spans from $12 at the low end to $19 at the high end, suggesting a potential 56.59% change from the previous closing price of $9.03.

How does Ardent Health Partners stock forecast compare to its benchmarks?

Ardent Health Partners's stock forecast shows a 56.59% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical care facilities stocks industry (24.44%).

What is the breakdown of analyst ratings for Ardent Health Partners over the past three months?

  • March 2026: 7.69% Strong Buy, 53.85% Buy, 30.77% Hold, 0% Sell, 7.69% Strong Sell.
  • February 2026: 7.69% Strong Buy, 53.85% Buy, 30.77% Hold, 0% Sell, 7.69% Strong Sell.
  • January 2026: 7.69% Strong Buy, 53.85% Buy, 30.77% Hold, 0% Sell, 7.69% Strong Sell.

What is Ardent Health Partners’s EPS forecast?

Ardent Health Partners's average annual EPS forecast for its fiscal year ending in December 2026 is $2.19, marking a 128.12% increase from the reported $0.96 in 2025. Estimates for the following years are.

What is Ardent Health Partners’s revenue forecast?

Ardent Health Partners's average annual revenue forecast for its fiscal year ending in December 2026 is $6.68B, reflecting a 5.66% increase from the reported $6.32B in 2025. The forecast for.

What is Ardent Health Partners’s net income forecast?

Ardent Health Partners's net income forecast for the fiscal year ending in December 2026 stands at $314.47M, representing an 131.55% increase from the reported $135.81M in 2025. Projections indicate .